Application Sponsors
ANDA 077293 | LEADING PHARMA LLC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 20MG | 0 | FUROSEMIDE | FUROSEMIDE |
002 | TABLET;ORAL | 40MG | 0 | FUROSEMIDE | FUROSEMIDE |
003 | TABLET;ORAL | 80MG | 0 | FUROSEMIDE | FUROSEMIDE |
FDA Submissions
| ORIG | 1 | AP | 2005-11-09 | |
LABELING; Labeling | SUPPL | 3 | AP | 2007-06-29 | |
LABELING; Labeling | SUPPL | 4 | AP | 2016-05-12 | |
LABELING; Labeling | SUPPL | 8 | AP | 2016-05-12 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
LEADING PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 77293
[companyName] => LEADING PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"FUROSEMIDE","activeIngredients":"FUROSEMIDE","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FUROSEMIDE","activeIngredients":"FUROSEMIDE","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FUROSEMIDE","activeIngredients":"FUROSEMIDE","strength":"80MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"FUROSEMIDE","submission":"FUROSEMIDE","actionType":"20MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"FUROSEMIDE","submission":"FUROSEMIDE","actionType":"40MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"FUROSEMIDE","submission":"FUROSEMIDE","actionType":"80MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)